Home › Funds › Rock Springs Capital Management LP › MDGL

Rock Springs Capital Management LP position in MDGL

MADRIGAL PHARMACEUTICALS INC · Health Care

Rock Springs Capital Management LP reported holding 177,249 shares of MDGL (MADRIGAL PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$89.3M, representing 4.83% of its reported portfolio and ranking #4 among its reported holdings. Rock Springs Capital Management LP has disclosed MDGL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)177.25K sh
Reported value held$89.33M
Portfolio Weight4.83%
First reportedQ3 2023
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Rock Springs Capital Management LP's MDGL position evolved

Rock Springs Capital Management LP first disclosed a stake in MDGL in Q3 2023 at 196,369 shares (US$28.7M). The position peaked in Q2 2026 at 174,999 shares, worth US$94.0M. Across 13 filings, Rock Springs Capital Management LP increased the stake 8 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 177,249 shares valued at US$89.3M — an increase of 2,250 shares quarter over quarter.. Notable position changes include a 44% increase in Q1 2024 (shares rose 5% over the following quarter), a 37% trim in Q1 2025 (shares fell 9% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 196.37K $28.68M New
Q4 2023 198.17K $45.85M Add
Q1 2024 285.93K $76.36M Add
Q2 2024 245.50K $68.78M Reduce
Q3 2024 263.06K $55.83M Add
Q4 2024 265.21K $81.84M Add
Q1 2025 166.70K $55.22M Reduce
Q2 2025 140.30K $42.46M Reduce
Q3 2025 137.75K $63.18M Reduce
Q4 2025 139.62K $81.31M Add
Q1 2026 171.00K $89.51M Add
Q2 2026 175.00K $93.97M Add
Q3 2026 177.25K $89.33M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MDGL and 13F data

MDGL (MADRIGAL PHARMACEUTICALS INC) is a Health Care company. 45 other funds we track also report a position in MDGL — the largest reported positions include BAKER BROS. ADVISORS LP (US$1.15B), Janus Henderson Group (US$1.05B), Jupiter Topco LLC (US$1.04B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MDGL

All MDGL fund holders →

FAQ

How long has Rock Springs Capital Management LP held MDGL?

Rock Springs Capital Management LP has disclosed MDGL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Rock Springs Capital Management LP's current position in MDGL?

As of Q3 2026, Rock Springs Capital Management LP holds 177.25K shares of MDGL (MADRIGAL PHARMACEUTICALS INC), valued at $89.33M, representing 4.83% of its reported portfolio and ranking #4.

Has Rock Springs Capital Management LP been buying or selling MDGL?

In the latest 13F filing (Q3 2026), Rock Springs Capital Management LP increased its position in MDGL. The position peaked in Q2 2026 at 175.00K shares.

Which other funds hold MDGL?

Other major institutional holders of MDGL include BAKER BROS. ADVISORS LP, Janus Henderson Group, Jupiter Topco LLC, among 45 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.